FIG. 1.

(A, B) The mobilization of BM-CPCs was analyzed immediately pre- and post- and at 3, 6, and 12 months postprocedure in both groups. CD34/45⁺ and CD133/45⁺ BM-CPC mobilization significantly increased at 3, 6, and 12 months after BMCs-Tx compared with baseline, whereas no significant differences were observed between immediately pre- and postprocedure in both groups. There were no significant changes in the mobilization of BM-CPCs at 3, 6, and 12 months after coronary angiography compared with baseline in the control group without cell therapy. Moreover, there were significant differences of BM-CPC mobilization at 3, 6, and 12 months after procedure between both groups. BM-CPCs, bone marrow-derived circulating progenitor cells; BMC-Tx, bone marrow cell transplantation; WBCs, white blood cells. Color images available online at www.liebertonline.com/scd